cancer

envie a um amigo share this

Tumor Immunology and Immunotherapy: harnessing the immune system to fight cancer

Auditorium BMW2, O&N2, campus Gasthuisberg, Leuven, Belgium

 

12 - 14 September, 2016

 

See more informations here: https://kuleuvencongres.be/leuvenimmuno2016/

A strategic moment - Prevention is better than cure

The world spends billions on trench warfare with cancer and makes slow progress with heavy collateral damage. New knowledge about the process of carcinogenesis and tumour growth is now fuelling calls for a change of strategy to focus on containing potential trouble and keeping the peace.

 

You can read more here: http://www.cancerworld.org/Articles/Issues/70/January-February-2016/Cutting-Edge/752/A-strategic-moment.html

A strategic moment - Prevention is better than cure

The world spends billions on trench warfare with cancer and makes slow progress with heavy collateral damage. New knowledge about the process of carcinogenesis and tumour growth is now fuelling calls for a change of strategy to focus on containing potential trouble and keeping the peace.

 

You can read more here: http://www.cancerworld.org/Articles/Issues/70/January-February-2016/Cutting-Edge/752/A-strategic-moment.html

Beatson International Cancer Conference: Modelling the Mechanisms of Malignancies - In Vivo Veritas

Glasgow University, Glasgow, United Kingdom

 

03-06 July, 2016

 

See more informations here: http://www.beatson.gla.ac.uk/beatson-conference/beatson-international-cancer-conference.html

Beatson International Cancer Conference: Modelling the Mechanisms of Malignancies - In Vivo Veritas

Glasgow University, Glasgow, United Kingdom

 

03-06 July, 2016

 

See more informations here: http://www.beatson.gla.ac.uk/beatson-conference/beatson-international-cancer-conference.html

Conversation with James Allison from the JCI series «Conversations with Giants in Medicine»

We decided to republish in ASPIC's website the interview below:

 

 

Interview with James Allison of the MD Anderson Cancer Center, who has made key discoveries on the regulation of T cell activation and modulation. He was awarded the 2015 Lasker DeBakey Clinical Medical Research Award in honor of his discovery and subsequent development of CTLA-4–targeted monoclonal antibody therapy to unleash the immune response to cancer.

 

See the interview here: http://www.jci.org/videos/104

Conversation with James Allison from the JCI series «Conversations with Giants in Medicine»

We decided to republish in ASPIC's website the interview below:

 

 

Interview with James Allison of the MD Anderson Cancer Center, who has made key discoveries on the regulation of T cell activation and modulation. He was awarded the 2015 Lasker DeBakey Clinical Medical Research Award in honor of his discovery and subsequent development of CTLA-4–targeted monoclonal antibody therapy to unleash the immune response to cancer.

 

See the interview here: http://www.jci.org/videos/104

DNA Damage, Mutation & Cancer: Genome Instability from Environmental and Inherent Sources of DNA Damage

Ventura Beach Marriott, Ventura, CA, United States

 

13 - 18 March, 2016

 

See more informations here: http://www.grc.org/programs.aspx?id=12940

Cancer incidence will keep rising up to 2020, in the North Region of Portugal

Cancer incidence will keep rising up to 2020, in the North Region of Portugal. According to the North Region Cancer Registry (RORENO), 10236 new cases will be diagnosed in that year. Women will experience the steepest increase, mainly due to thyroid and lung cancers. For the same period, a decreasing trend in the number of new cases is expected for cancer of the cervix. This study contributed to a broader understanding of the population’s cancer burden, useful for the implementation of cancer control measures.

 

Authors and Affiliations:

Supramolecular nanoscale assemblies for cancer diagnosis and therapy

Authors and Affiliations:

Sílvia Castro Coelho1, Maria Carmo Pereira1, Asta Juzeniene2, Petras Juzenas2, Manuel Álvaro Coelho1

 1 LEPABE, Department of Chemical Engineering, Faculty of Engineering, University of Porto, Rua Roberto Frias, PT-4200-465 Porto, Portugal

2 Department of Radiation Biology, Institute for Cancer Research, Radiumhospital, Oslo University Hospital, NO-0310 Oslo, Norway

 

Abstract: